Premium
Retraction: Behr TM, Griesinger F, Riggert J, et al. High‐dose myeloablative radioimmunotherapy of mantle cell non‐hodgkin lymphoma with the iodine‐131‐labeled chimeric anti‐CD20 antibody C2B8 and autologous stem cell support: results of a pilot study. Cancer . (2002) 94(4 Suppl):1363–72.
Publication year - 2005
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.21658
Subject(s) - radioimmunotherapy , medicine , mantle cell lymphoma , lymphoma , cancer research , antibody , nuclear medicine , oncology , monoclonal antibody , immunology
The original article to which this Retraction refers was published in Cancer (2002) 94(4 Suppl):1363–72.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom